Anonymous ID: 7217f5 Feb. 2, 2019, 12:38 p.m. No.5004656   🗄️.is 🔗kun   >>4664 >>5146 >>5172 >>5238

[lb / notables]

>>5003856

>Prominent Cancer Center Faces Reckoning Over Industry Ties

If you would like to read more about the doctor thaat did not disclose his kickbacks from big phama and then was hired by the same company after leaving Kettering …here is more info

 

Bread 5945

>>4659364

>>4659281

MSK Cancer Center Orders Staff to ‘Do a Better Job’ of Disclosing Industry Ties

www.nytimes.com/2018/09/09/health/cancer-memorial-sloan-kettering-disclosure.html

>Dr. Baselga received nearly $3.5 million in payments from drug, medical equipment and diagnostic companies from August 2013 through 2017, according to Open Payments, a federal database that tracks payments to physicians from health care companies.

>The bulk of that amount, about $3 million, involved a payment from Genentech, a subsidiary of the Swiss pharmaceutical giant Roche, for Dr. Baselga’s ownership interest in a company it acquired, Seragon Pharmaceuticals, in 2014.

Bread 5944

>>4658875

Anonymous ID: 7217f5 Feb. 2, 2019, 12:39 p.m. No.5004664   🗄️.is 🔗kun   >>5146 >>5172 >>5238

>>5004656

Bread 5944

>>4658875

Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks

AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research unit.

www.propublica.org/article/astrazeneca-hires-dr-jose-baselga/amp

Anonymous ID: 7217f5 Feb. 2, 2019, 12:54 p.m. No.5004819   🗄️.is 🔗kun   >>4841

How does this happen? CNN should apologize to their viewers.

#FactsFirst 🍎

twitter.com/GOPChairwoman/status/1091721907626479616